Investors didn't show much interest in one Deciphera Pharmaceuticals way or another today. It hasn't moved too much today but is slightly down, it lost -0.84% since yesterday.
Currently DCPH isn't at a clear support/resistance line that seems tradable. Deciphera Pharmaceuticals hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. DCPH might find some support at the 20.23 level, buyers might push the price back up from here. But it's not very clear what will happen.
Deciphera Pharmaceuticals has an overall positive view by the analysts. The current Analysts Sentiment Score is 171.54. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. On 2023-02-08 HC Wainwright reiterated their rating of Buy and added a price target of $25.00. SVB Leerink boosted their price targ by 7.14% to $30.00 on 2023-02-07. Cowen gave a boost to their price target and moved to $30.00 from $25.00 on 2023-01-25. On 2023-01-06 there was an upgrade provided by Jonestrading from Sell to Hold. On 2023-01-04 Barclays increased their price target by 12.5% to $9.00. Guggenheim upgraded from Neutral to Buy on 2023-01-04 and they set their price target at $22.00. On 2022-09-27 Stifel Nicolaus increased their price target by 63.64% to $18.00. Piper Sandler gave a boost to their price target and moved to $18.00 from $13.00 on 2022-09-11. Cowen initiated a rating of Outperform on 2022-08-29 and added a price target of $25.00. JMP Securities upgraded from Market Perform to Outperform on 2022-08-05 and added a price target of $23.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| DCPH | 171.54 | 167.83 | -0.45 | 176.34 | -0.65 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| DCPH | 23.51 | 0.64 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| DCPH | 15.71 | %16.1 | 13.9 | 8.25 | 7680000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 367 | 1.85 | -0.88 | -10.56 | 1.85 | -7.04 | -22.15 | 31.57 | -13.77 | -17.27 | -13.81 | -41814.93 | -3164.24 | 0.95 | 21.19 | 6.54 | 48.84 |
| Healthcare | 617 | 2.00 | -0.17 | -8.49 | 2.07 | -6.13 | -23.93 | 31.85 | -11.33 | -14.45 | -14.07 | -36805.91 | -4054.41 | 1.05 | 22.33 | 5.93 | 36.37 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| DCPH | 3.00 |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRIS | Curis Inc | 0.92 | -1.02 | -4.22 | -21.67 | 0.08 | -35.25 | -80.69 | 26 | -5.83 | -24.51 | -25.77 | -42364.75 | -579.58 | 0 | 0 | 3.06794 |
| NKTR | Nektar Therapeutics | 0.89 | -6.21 | -23.38 | -70.98 | -62.02 | -74.31 | -84.65 | 14 | -70.97 | -69.26 | -53.69 | -41567.49 | 0.00 | 0 | 0 | 3.34566 |
| GTHX | G1 Therapeutics, Inc. Com | 0.87 | 7.14 | -3.67 | -16.45 | -45.03 | -77.89 | -61.96 | 30 | -70.01 | -64.39 | -39.25 | -25686.68 | 0.00 | 0 | 0 | 7.14626 |
| NVTA | Invitae Corporation | 0.84 | 9.09 | -5.71 | -35.92 | -30.16 | -55.10 | -83.42 | 24 | -40.57 | -63.71 | -81.94 | -50905.73 | 0.00 | 0 | 125 | 11.8279 |
| BLUE | bluebird bio, Inc. Common | 0.81 | 2.91 | -1.08 | -14.50 | -38.42 | -32.94 | -8.00 | 36 | -20.05 | -11.68 | -7.21 | -23468.93 | -1597.03 | 0 | 0 | 15.1694 |
| VCYT | Veracyte, Inc. | 0.81 | 3.29 | 1.44 | -2.76 | -12.20 | 28.54 | -14.62 | 38 | 7.60 | 9.72 | 15.50 | -17160.89 | -1908.81 | 0 | 0 | 4.12529 |
| VKTX | Viking Therapeutics, Inc | 0.8 | -19.35 | -12.17 | -14.65 | 15.95 | 205.54 | 188.62 | 32 | 93.72 | 128.46 | 106.04 | -2064.43 | -23764.37 | 0 | 0 | 1.84923 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
